Literature DB >> 10393856

Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas.

S Wang1, I B Rosenwald, M J Hutzler, G A Pihan, L Savas, J J Chen, B A Woda.   

Abstract

Transition of cells from quiescence to proliferation requires an increase in the rate of protein synthesis, which is regulated in part by two key translation initiation factors, 4E and 2alpha. The expression and activity of both factors are increased transiently when normal resting cells are stimulated to proliferate. They are constitutively elevated in oncogene transformed cultured cells, and overexpression of either initiation factor in rodent cells makes them tumorigenic. In this study we investigate an association between the expression of translation initiation factors and lymphomagenesis. We have analyzed the expression of the protein synthesis initiation factors 4E and 2alpha by immunohistochemistry in reactive lymph nodes and several types of non-Hodgkin's lymphoma representing a wide range of clinical behaviors based on the Revised European-American Lymphoma behavioral classification. The study included 7 benign lymph nodes with follicular hyperplasia, 26 indolent lymphomas (6 marginal zone lymphomas, 7 small lymphocytic lymphomas, and 13 follicular lymphomas, grades 1 and 2), 16 moderately aggressive lymphomas (8 mantle cell lymphomas and 8 follicular lymphomas, grade 3), 24 aggressive lymphomas (14 large-B-cell lymphomas and 10 anaplastic large-cell lymphomas), and 15 highly aggressive lymphomas (7 lymphoblastic lymphomas and 8 Burkitt's lymphomas). Strong expression of initiation factors 4E and 2alpha was demonstrated in the germinal centers of reactive follicles. Minimal or no expression was seen in the mantle zones and surrounding paracortices, indicating that high expression of initiation factors 4E and 2alpha is associated with the active proliferation of lymphocytes. Most cases of aggressive and highly aggressive lymphomas showed strong expression of initiation factors 4E and 2alpha, in contrast to the cases of indolent and moderately aggressive lymphoma, in which their expression was intermediate between the germinal centers and the mantles of reactive follicles. A positive correlation was found between the expression of both initiation factors 4E and 2alpha and the Revised European-American Lymphoma behavior classification (P < 0.05). Thus, constitutively increased expression of initiation factors 4E and 2alpha may play an important role in the development of lymphomas and is correlated with their biological aggressiveness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393856      PMCID: PMC1866670          DOI: 10.1016/s0002-9440(10)65118-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells.

Authors:  I B Rosenwald
Journal:  Cancer Lett       Date:  1996-04-19       Impact factor: 8.679

2.  Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation.

Authors:  C Kevil; P Carter; B Hu; A DeBenedetti
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

Review 3.  Growth control of translation in mammalian cells.

Authors:  D R Morris
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

4.  Growth factor-independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines.

Authors:  I B Rosenwald
Journal:  Cancer Lett       Date:  1995-11-27       Impact factor: 8.679

Review 5.  Revised European-American Lymphoma Classification.

Authors:  S A Pileri; L Leoncini; B Falini
Journal:  Curr Opin Oncol       Date:  1995-09       Impact factor: 3.645

6.  Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma-linked chromosomal translocation junction gene on 11q23.

Authors:  M Seto; K Yamamoto; T Takahashi; R Ueda
Journal:  Gene       Date:  1995-12-12       Impact factor: 3.688

7.  Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts.

Authors:  J R Graff; E R Boghaert; A De Benedetti; D L Tudor; C C Zimmer; S K Chan; S G Zimmer
Journal:  Int J Cancer       Date:  1995-01-17       Impact factor: 7.396

8.  Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.

Authors:  I B Rosenwald; R Kaspar; D Rousseau; L Gehrke; P Leboulch; J J Chen; E V Schmidt; N Sonenberg; I M London
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

9.  Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis.

Authors:  C G Kevil; A De Benedetti; D K Payne; L L Coe; F S Laroux; J S Alexander
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

10.  Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.

Authors:  I B Rosenwald; A Lazaris-Karatzas; N Sonenberg; E V Schmidt
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more
  53 in total

1.  The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Authors:  Ivan Topisirovic; Biljana Culjkovic; Natalie Cohen; Jacqueline M Perez; Lucy Skrabanek; Katherine L B Borden
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 2.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

3.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

Review 4.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 5.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

6.  Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Francisco Vega; L Jeffrey Medeiros; Vasiliki Leventaki; Coralyn Atwell; Jeong Hee Cho-Vega; Ling Tian; Francois-Xavier Claret; George Z Rassidakis
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

7.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors.

Authors:  Sonia Tejada; M Val T Lobo; Mercedes García-Villanueva; Silvia Sacristán; M Isabel Pérez-Morgado; Matilde Salinas; M Elena Martín
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

9.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

10.  Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions.

Authors:  Yi-Jiun Chen; Bertrand Chin-Ming Tan; Ya-Yun Cheng; Jin-Shin Chen; Sheng-Chung Lee
Journal:  Nucleic Acids Res       Date:  2009-11-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.